Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas | MicrobiomeTrials← Back to trialsNCT06176690
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2025-10-27Est. Completion: 2028-07-27
Enrollment target: 90 participants Locations- Houston Methodist Hospital, Houston, Texas, United States
- Texas Children's Hospital, Houston, Texas, United States
Other microbiome trials you might be interested in
Diffuse Large B-cell Lymphoma
Participants in this study will have diffuse large B-cell lymphoma (DLBCL) that has come back or not gotten better with …
Birmingham, United StatesEst. completion Jan 23, 2026
Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeClassical Hodgkin Lymphoma
This study involved patients that have a cancer called diffuse large B cell lymphoma (DLBCL), NK and T cell lymphomas (N…
Houston, United StatesEst. completion Jun 1, 2027